Shortage Watch Free FDA drug-shortage watch

← all medications

Oseltamivir Phosphate Capsule

Category: Antiviral

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Sep 30, 2025 · First posted: Sep 30, 2025 · 1 manufacturers, 1 listed presentations

As of Sep 30, 2025, the FDA lists Oseltamivir Phosphate Capsule as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Oseltamivir Phosphate Capsule is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Tamiflu, Capsule, 45 mg (NDC 0004-0801-85)
NDC 0004-0801-85		 Genentech, Inc Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Antiviral medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Oseltamivir Phosphate Capsule (FDA data as of Sep 30, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Oseltamivir Phosphate Capsule. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Oseltamivir Phosphate Capsule.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/oseltamivir-phosphate-capsule.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).